3412 results for «2022»
3412 results
Acute outcomes for the full US cohort of the FLASH Mechanical Thrombectomy Registry in pulmonary embolism
21 Sep 2022
Waqar Ahmed provides his take on the FLASH Mechanical Thrombectomy Registry which was presented by Catalin Toma at TCT 2022.
The article was simultaneously published in the EuroIntervention Journal: Acute Outcomes for the Full US Cohort of the FLASH Mechanical Thrombectomy Registry in Pulmonary Embolism. EuroIntervention, C. Toma et al. DOI:...
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Celebrating the 2023 International Day of Interventional Cardiology
15 Sep 2023
We are proud to celebrate the International Day for Interventional Cardiology, established by a resolution of the United Nations in September 2022 to raise public awareness of cardiovascular diseases and procedures, related complications as well as prevention and care. The resolution notes that interventional cardio-angiology improves health,...
Author
CHOICE CLOSURE - Proven benefits from a randomised trial of suture-based closure device strategy for transfemoral transcatheter aortic valve replacement
17 May 2022 – From EuroPCR 2022
Watch this presentation of the CHOICE CLOSURE trial proposed by Mohamed Abdel-Wahab for EuroPCR 2022 to understand the benefits of suture-based strategy in terms of access-site or access-related major and minor vascular complications, to compare suture-based to plug-based closure in large-bore arterial access, and to analyze...
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Introducing the new #PCRLV Course Directors
Revascularisation for Ischemic heart failure: is PCI as good as CABG?
27 Sep 2022
Pamela Gatto interviews Volkmar Falk, Cardiovascular Surgeon, and Dejan Milasinovic, Interventional Cardiologist, to get their perspective about the results of the REVIVED-BCIS2 trial.
The 3 questions are:
- What were your first thoughts and feelings when the findings from REVIVED were presented at ESC 2022?
- In STICH(es), CABG had a...
Browse a #PCRLV Final Programme to enjoy onsite or online!
CLASP II D: A randomized comparison of TEER devices for degenerative mitral regurgitation
20 Sep 2022
Luigi Biasco interviews Scott Lim and Konstantinos P. Koulogiannis, Principal Investigators of CLASP IID.
The trial demonstrated safety and effectiveness of the PASCAL system and met non-inferiority endpoints, expanding transcatheter treatment options for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation.
Author
Author
Author
RTC - Radial versus femoral access for coronary procedures
29 Aug 2022
Thirty years after the first radial access interventional coronary procedure the RTC trial provides evidence that radial access for coronary angiography or PCI is associated with lower risks of all-cause death and bleeding compared with femoral access. Mirvat Alasnag interviews Giuseppe Gargiulo regarding the methodology and...
Author
Author
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction
28 Aug 2022
Ali Nazmi Calik asks trial investigator John Alexander about the design and results of the PACIFIC-AMI phase 2 trial, which revealed no increase in bleeding versus placebo.
Author
Author
How should I treat a STEMI - A patient's journey - With Angola & Sudan
02 Sep 2022
Watch the replay of #AfricaPCR 2022’s live webinar on STEMI.
Optimising TAVI patients’ journey
11 Aug 2022
The PCR Webinars in this series are all accredited. They may be watched independently, although it is preferable to view the full series in the correct order for a prime educational experience.
Coordinator:Nicolas Dumonteil@nicolasdumonte1
How can I mitigate complications for my TAVI patients?
11 Aug 2022
Coordinator:Stephen Worthley
Lifetime management of patients with aortic stenosis
02 Dec 2022
Watch the 2nd PCR Tokyo Valves 2022 webinar on aortic stenosis.
Attend Alfieri's Boot Camp: map, visas & letter of invitation!
Attend the Advanced Course on Transseptal Puncture in Milan: registration, credits, visas & letter of invitation!
Season’s greetings from the PCR Chairman and Vice-Chairman
19 Dec 2022
How should I treat a pregnant woman with mitral stenosis - A patient's journey
29 Sep 2022
Watch the replay of the 2nd of #AfricaPCR 2022’s four live webinars on valvular disease.
How to refine my TAVI procedure to ensure optimal long-term patient outcomes?
11 Aug 2022
Coordinator:Lars Sondergaard
